They express natural killer cell activating receptors for additional synergistic effects, eliminate tumor-associated immunosuppressive macrophages, reprogram favorable tumor immune-microenvironment, and enhance adaptive ant-tumor immunity via CD40-CD40L feedback loop (10–12). The gene discussed is CD40LG; the disease is neoplasm.